Protein Formulation Stability Evaluation via Interfacial Tension
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The stability of protein-based formulations in lubricated containers, such as prefilled injection devices, is challenging due to interactions with lubricants like silicone oils, leading to degradation and aggregation of proteins, which can result in stability issues and safety concerns, and there is a need for a fast and efficient method to evaluate and improve formulation stability and select appropriate lubricants.
Innovation Solution
A method using interfacial tension measurements to evaluate the stability of protein-based formulations by comparing the decrease in interfacial tension between the formulation and the lubricant, identifying interacting components, and adapting the formulation with adjuvants like Polysorbate 80 or aluminum hydroxide to prevent undesirable interactions, thereby selecting a compatible lubricant or reformulating the protein-based formulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If silicone-based lubricants are used in prefilled injection devices, then the gliding performance of the stopper is improved, but protein degradation and aggregation occur leading to formulation instability
Solution Approach 1:
The patent introduces an intermediary substance (surfactant or protective colloid) between the protein formulation and silicone lubricant to prevent direct interaction. The intermediary competes for interaction with the silicone, forming a protective barrier that prevents protein adsorption and aggregation while allowing the stopper to glide smoothly.
Solution Approach 2:
The patent modifies the chemical parameters of the formulation by adding specific substances (surfactants like polysorbates or protective colloids like albumin) that change the interfacial properties. These parameter changes reduce the affinity between protein and silicone, preventing degradation while maintaining lubrication functionality.
2Reliability
If interfacial tension measurements are performed to evaluate formulation stability, then early detection of stability issues is enabled, but additional testing time and complexity are required
Solution Approach 1:
The patent performs interfacial tension measurements as a preliminary screening tool before final formulation validation. By conducting this test early in the development process, potential compatibility issues are detected before committing to extensive clinical trials or manufacturing scale-up, saving time and resources in the long run.
Solution Approach 2:
The patent replaces complex, time-consuming stability studies (such as long-term accelerated stability testing) with a simpler interfacial tension measurement approach. This substitution provides rapid assessment of formulation-lubricant compatibility, reducing the overall testing timeline while maintaining reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for early detection of stability issues, reduces costly reformulation steps, and ensures the stability of protein-based formulations by identifying and mitigating interactions with lubricants, thereby enhancing the safety and efficacy of pharmaceutical products.
Implementation Method 1
Evaluating a decrease over time of interfacial tension between the buffer and the lubricant, Evaluating a decrease over time of interfacial tension between the protein-based formulation and the lubricant
Data Source
AI summary
Disclosed herein is a method to evaluate the stability of a protein-based formulation including a protein, a peptide and/or a protein derivative and a buffer relative to a lubricant of a lubricated container in which the formulation is intended to be stored, including: a) Evaluating a decrease over time of interfacial tension between the buffer and the lubricant, b) Evaluating a decrease over time of interfacial tension between the protein-based formulation and the lubricant, c) Identifying at least one component of the protein-based formulation interacting with the lubricant by comparing the decrease evaluated in step b) with the decrease evaluated in step a).